

Page 58
conferenceseries
.com
6
th
World Congress on
October 16-18, 2017 | San Francisco, USA
Breast Cancer & Therapy
Volume 2, Issue 5 (Suppl)
Breast Can Curr Res, an open access journal
Breast Cancer Congress 2017
October 16-18, 2017
Plantago Ovata
(Esfarzeh) in prevention and treatment of acute radiation dermatitis
Ali Tavakoli
Shiraz University of Medical Sciences, Iran
Introduction:
Plantago Ovata
is one of medicinal plants for treatment of dermatitis with a long history of use in traditional medicine
(TM) references. New studies have also proved its antioxidant, immunomodulatory, anti-inflammatory and wound healing properties.
The aim of this study is to suggest a compound derived from
Plantago Ovata
(taken from TM) for treatment of acute radiation
dermatitis (ARD).
Results:
In TM, the seed isolated from
Plantago ovata
called “Esfarzah” is considered as an anti-inflammatory drug, so topical
application of it is recommended for treatment of dermatitis. It is also moisturizing, softener and skin fattening in its properties, that
increases skin flexibility. This latter property (moisturizing) is an ideal method for preventing and minimizing skin reactions that is
generally agreed in a systematic review. Esfarzah would be useful to treat dermatitis if mixed with rose oil and soaked in water until
its mucilage is extracted and then applied topically. This traditional formulation with this method of preparation is our suggestion for
treatment of ARD. However, it is required that this formulation be prepared in form of cream and on industrial scale.
Conclusions:
We claim that this compound not only is moisturizing, which increases skin flexibility and helps in keeping trans
epidermal water (a measure for skin barrier integrity) that is effective for prevention of ARD, but also relieves inflammation as well
as skin healing due to creating mucilage that is effective for treatment of ARD. So, it is imperative that researches be performed to
prove these therapeutic effects.
tavakkolia@sums.ac.irBreast Can Curr Res 2017, 2:5 (Suppl)
DOI: 10.4172/2572-4118-C1-012